Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
AI Lab Martech Sdn Bhd TGL Treasure Global Inc 13G 14.49% 3y
Wilson Su AKAN Akanda Corp. 13G 15.5% 3y
BROWN CAPITAL MANAGEMENT LLC APPF Appfolio Inc 13G/A 8.65% 3y
Beijing Zhongyun Ronghui Investment Center, LLP CCG Cheche Group Inc. 13G 6.5% 3y
Pfizer Inc ALLO Allogene Therapeutics, Inc. 13D/A 13.14% 3y
STROME MARK E BEAT HeartBeam, Inc. 13D 12% 3y
David F. Welch CYDY CytoDyn Inc. 13G 5.5% 3y
Magnetar Financial LLC BARK Bark, Inc. 13G 5.72% 3y
TECTONIC ADVISORS LLC ABEQ Unified Series Trust 13G/A 21.1% 3y
Hendricks Factual Media LLC CURI CuriosityStream Inc. 13D/A 41.1% 3y
TECTONIC ADVISORS LLC ABEQ Unified Series Trust 13G/A 32.3% 3y
Arturo R. Moreno OUT OUTFRONT Media Inc. 13D 4.4% 3y
ThoughtValley Limited Partnership ASLE AerSale Corp 13D/A 7% 3y
Paragon Technologies, Inc. OPTT Ocean Power Technologies, Inc. 13D/A 3.9% 3y
Nicolas Finazzo ASLE AerSale Corp 13D/A 8.4% 3y
Angeliki Frangou NMPGY Navios Maritime Holdings Inc. 13D/A 64.8% 3y
Harraden Circle Investments, LLC CDAQF Compass Digital Acquisition Corp. 13G 9.49% 3y
KENNEDY LEWIS MANAGEMENT LP FXLV F45 Training Holdings Inc. 13D/A 14.4% 3y
Stammtisch Investments LLC WULF Terawulf Inc. 13D/A 20.2% 3y
Saba Capital Management, L.P. NQP NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND 13D/A 9.46% 3y
Saba Capital Management, L.P. BMEZ BlackRock Health Sciences Term Trust 13D/A 10.06% 3y
Rafael Holdings, Inc. CYTH Cyclo Therapeutics, Inc. Common Stock 13D/A 49% 3y
Casdin Capital, LLC BLFS Biolife Solutions Inc 13D/A 19.5% 3y
Thomas O. Hicks BENF Beneficient 13D/A 0.6% 3y
MILLENNIUM MANAGEMENT LLC ITOS iTeos Therapeutics, Inc. Common Stock 13G 5.8% 3y
Teoxane SA RVNC Revance Therapeutics, Inc. 13D/A 7.4% 3y
ERIKSEN CAPITAL MANAGEMENT LLC SODI Solitron Devices Inc 13D/A 12.7% 3y
Madryn Asset Management, LP GBNH Greenbrook TMS Inc. Common Shares 13D/A 45% 3y
Squarepoint Ops LLC VNTR Venator Materials PLC 13D 17.1% 3y
Morsevo Trading, Inc. KARX Karbon-X Corp. 13D 5.8% 3y
Arena Capital Advisors, LLC- CA HCVI Hennessy Capital Investment Corp. VI Class A Common Stock 13G 12.1% 3y
Jonathan B. Rubini GMVD G Medical Innovations Holdings Ltd. Ordinary Shares 13D/A 23.3% 3y
Gerald E. O’Shaughnessy GPRK GeoPark Ltd 13D/A 7.26% 3y
Capital World Investors DBD DIEBOLD NIXDORF, Inc 13D/A 33.4% 3y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 6.5% 3y
Saudi Arabian Mining Company (Ma’aden) IE Ivanhoe Electric Inc. 13D/A 8.7% 3y
Bleichroeder LP INVE INVE Technologies, Inc. 13D/A 19.9% 3y
EW Healthcare Partners, L.P. VERO Venus Concept Inc. 13D/A 44.2% 3y
PERCEPTIVE ADVISORS LLC SLNO Soleno Therapeutics Inc 13D/A 10.1% 3y
Mayfield XV, a Cayman Islands Exempted Limited Partnership GROV Grove Collaborative Holdings, Inc. 13D/A 3.6% 3y
Scott Stanford ASTR Astra Space, Inc. Class A Common Stock 13D/A 8.6% 3y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 12.65% 3y
Saba Capital Management, L.P. PGZ Principal Real Estate Income Fund 13D/A 8.43% 3y
Schindel Yair Chaim ADXS Advaxis, Inc. 13G/A 5.21% 3y
Avidity Partners Management LP FUSN Fusion Pharmaceuticals Inc. Common Shares 13G 9.7% 3y
Corvex Management LP SWX Southwest Gas Holdings, Inc. 13D 5.8% 3y
Exor N.V. CLVT Clarivate PLC 13D 6.29% 3y
Silver Point Capital L.P. PRTY Party City Holdco Inc. 13D 41% 3y
Cormorant Asset Management, LP ALPN Alpine Immune Sciences, Inc. Common Stock 13G 5.79% 3y
Kontron AG BSQR BSQUARE Corporation 13D 17.3% 3y